A Study of Pegylated Liposomal Doxorubicin & Cyclophosphamide in

Status Recruiting

Clinical Trial Summary

Primary objective:

- To evaluate the disease-free survival (DFS) in the two randomized arms after therapy with LC vs. EC in chemo-naive Her2-patients with stage I or II breast cancer

Secondary objectives:

- To assess the overall survival (OS)

- To establish the safety profile by assessing the toxicities and tolerability

- To assess the quality of life (QoL)

- To evaluate survival correlation with biomarkers expression.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01210768
Study type	Interventional
Source	TTY Biopharm
Contact
Status	Recruiting
Phase	Phase 2
Start date	June 2010
Completion date	August 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03095352` - A Randomized Phase II Study of Pembrolizumab, an Anti-PD (Programmed Cell Death)-1 Antibody, in Combination With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease	Phase 2
Active, not recruiting	`NCT01472094` - Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
Recruiting	`NCT03284957` - Phase 1 / 2 Study of SAR439859 Single Agent and in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer	Phase 1/Phase 2
Recruiting	`NCT03544762` - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation	Phase 3
Completed	`NCT00341939` - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Active, not recruiting	`NCT01857193` - Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer	Phase 1
Recruiting	`NCT03432429` - REI-EXCISE iKnife Study	N/A
Active, not recruiting	`NCT02139358` - Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer	Phase 1/Phase 2
Completed	`NCT03323333` - Psychosocial Intervention Pilot for Partners in BRCA Testing	N/A
Terminated	`NCT01649258` - Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy	Phase 1
Completed	`NCT03384511` - The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.	Phase 4
Recruiting	`NCT01992432` - Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)	N/A
Completed	`NCT01943500` - Collection of Blood Specimens for Circulating Tumor Cell Analysis	N/A
Not yet recruiting	`NCT03433313` - Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer	Phase 3
Active, not recruiting	`NCT02371174` - Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.	N/A
Not yet recruiting	`NCT03273348` - Role of Oncoplastic Breast Surgery In Breast Cancer Treatement	N/A
Active, not recruiting	`NCT02225470` - Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes	Phase 3
Completed	`NCT01881230` - Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)	Phase 2/Phase 3
Recruiting	`NCT03237572` - Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer	Phase 1
Recruiting	`NCT03324932` - Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer	Phase 3

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms